{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:01:20Z","timestamp":1790359280117,"version":"4.1.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    In view of the rapidly increasing evidence that gene fusion mutations are frequent drivers of cancer, a deeper understanding of the molecular and functional hallmarks of specific gene fusions in epithelial ovarian cancer (EOC) is essential. In this work we sought to identify the molecular signature of the BCAM-AKT2 fusion protein in ovarian cancer cell lines and to assess the biological impact of the novel fusion in these cells. Our\n                    <jats:italic>in-vitro<\/jats:italic>\n                    results show that the BCAM-AKT2 fusion protein is engaged in proliferative action within EOC cell lines. Furthermore, RNA-seq analysis shows that the effect of BCAM-AKT2 in SKOV3 cells is associated with activated unfolded protein response (UPR) and with the inhibition of interferon alpha and beta signaling pathways, pyropstosis and viral response in EOC cell lines. Overall, our results indicate that in SKOV3 cells, BCAM-AKT2 modulates the UPR signaling pathway, which is known to interact with oncogene and tumor suppressor networks during cancer development. These findings offer fresh insights suggesting that BCAM-AKT2 could serve as a promising target for therapeutic interventions in ovarian cancer.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0357882","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:38:15Z","timestamp":1790357895000},"page":"e0357882","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["BCAM-AKT2 fusion protein promotes unfolded protein response driven oncogenic signaling in SKOV3 epithelial ovarian cancer cell line"],"prefix":"10.1371","volume":"21","author":[{"given":"Hala","family":"Khazem","sequence":"first","affiliation":[{"name":"Hillel Yaffe Medical Center","place":["Hadera, Israel"],"department":["Gynecologic Oncology Laboratory, Division of Obstetrics and Gynecology"]},{"name":"Technion - Israel Institute of Technology","place":["Haifa, Israel"],"department":["The Ruth and Bruce Rappaport Faculty of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3953-5988","authenticated-orcid":true,"given":"Ravid Solomon","family":"Zemler","sequence":"additional","affiliation":[{"name":"Hillel Yaffe Medical Center","place":["Hadera, Israel"],"department":["Gynecologic Oncology Laboratory, Division of Obstetrics and Gynecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3015-9349","authenticated-orcid":true,"given":"Liron Vardi","family":"David","sequence":"additional","affiliation":[{"name":"Hillel Yaffe Medical Center","place":["Hadera, Israel"],"department":["Gynecologic Oncology Laboratory, Division of Obstetrics and Gynecology"]},{"name":"Hillel Yaffe Medical Center","place":["Hadera, Israel"],"department":["Division of Obstetrics and Gynecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dvir","family":"Reder","sequence":"additional","affiliation":[{"name":"Hillel Yaffe Medical Center","place":["Hadera, Israel"],"department":["Gynecologic Oncology Laboratory, Division of Obstetrics and Gynecology"]},{"name":"Hillel Yaffe Medical Center","place":["Hadera, Israel"],"department":["Division of Obstetrics and Gynecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilhav Meisel","family":"Sharon","sequence":"additional","affiliation":[{"name":"Hillel Yaffe Medical Center","place":["Hadera, Israel"],"department":["Gynecologic Oncology Laboratory, Division of Obstetrics and Gynecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shay","family":"Hantisteanu","sequence":"additional","affiliation":[{"name":"Hillel Yaffe Medical Center","place":["Hadera, Israel"],"department":["Gynecologic Oncology Laboratory, Division of Obstetrics and Gynecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haim","family":"Werner","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical and Health Sciences, Tel Aviv University","place":["Tel Aviv, Israel"],"department":["Department of Human Molecular Genetics and Biochemistry"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-5462","authenticated-orcid":true,"given":"Ilan","family":"Bruchim","sequence":"additional","affiliation":[{"name":"Hillel Yaffe Medical Center","place":["Hadera, Israel"],"department":["Gynecologic Oncology Laboratory, Division of Obstetrics and Gynecology"]},{"name":"Technion - Israel Institute of Technology","place":["Haifa, Israel"],"department":["The Ruth and Bruce Rappaport Faculty of Medicine"]},{"name":"Hillel Yaffe Medical Center","place":["Hadera, Israel"],"department":["Division of Obstetrics and Gynecology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"pone.0357882.ref001","doi-asserted-by":"crossref","DOI":"10.1053\/j.seminoncol.2007.03.012","article-title":"The management of recurrent ovarian cancer","volume":"34","author":"RM Bukowski","year":"2007","journal-title":"Semin Oncol"},{"issue":"6","key":"pone.0357882.ref002","first-page":"561","article-title":"Ovarian Cancer: An overview","volume":"91","author":"SM Penny","year":"2020","journal-title":"Radiol Technol"},{"issue":"3","key":"pone.0357882.ref003","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"pone.0357882.ref004","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","article-title":"Clinical and translational advances in ovarian cancer therapy","volume":"4","author":"PA Konstantinopoulos","year":"2023","journal-title":"Nat Cancer"},{"issue":"37","key":"pone.0357882.ref005","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1038\/onc.2014.406","article-title":"The landscape and therapeutic relevance of cancer-associated transcript fusions","volume":"34","author":"K Yoshihara","year":"2015","journal-title":"Oncogene"},{"issue":"29","key":"pone.0357882.ref006","doi-asserted-by":"crossref","first-page":"46891","DOI":"10.18632\/oncotarget.16781","article-title":"Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes","volume":"8","author":"MA Earp","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"pone.0357882.ref007","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc2091","article-title":"The impact of translocations and gene fusions on cancer causation","volume":"7","author":"F Mitelman","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"pone.0357882.ref008","doi-asserted-by":"crossref","first-page":"912742","DOI":"10.1155\/2015\/912742","article-title":"The Structural Characterization of Tumor Fusion Genes and Proteins","volume":"2015","author":"D Wang","year":"2015","journal-title":"Comput Math Methods Med"},{"issue":"2","key":"pone.0357882.ref009","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/acsptsci.9b00019","article-title":"Molecular Signatures of Fusion Proteins in Cancer","volume":"2","author":"NS Latysheva","year":"2019","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"8","key":"pone.0357882.ref010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41419-021-04065-0","article-title":"Fusion genes in gynecologic tumors: the occurrence, molecular mechanism and prospect for therapy","volume":"12","author":"B Lu","year":"2021","journal-title":"Cell Death Dis"},{"issue":"11","key":"pone.0357882.ref011","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1501735112","article-title":"Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma","volume":"112","author":"K Kannan","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"pone.0357882.ref012","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior","volume":"47","author":"N Jiang","year":"2020","journal-title":"Mol Biol Rep"},{"issue":"1","key":"pone.0357882.ref013","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"Y He","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"pone.0357882.ref014","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1074\/jbc.M111.281782","article-title":"Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells","volume":"287","author":"R Sarfstein","year":"2012","journal-title":"J Biol Chem"},{"key":"pone.0357882.ref015","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"S Domcke","year":"2013","journal-title":"Nat Commun"},{"issue":"6","key":"pone.0357882.ref016","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.clon.2005.05.009","article-title":"Epithelial ovarian cancer: a review of current management","volume":"17","author":"AE Guppy","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"pone.0357882.ref017","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00280-012-2043-3","article-title":"Overcoming acquired resistance to anticancer therapy: Focus on the PI3K\/AKT\/mTOR pathway","volume":"71","author":"3rd Burris HA","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"pone.0357882.ref018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","article-title":"Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer","volume":"85","author":"L Yu","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"pone.0357882.ref019","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41540-022-00214-z","article-title":"CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy","volume":"8","author":"M Salgado-Albarr\u00e1n","year":"2022","journal-title":"NPJ Syst Biol Appl"},{"issue":"5","key":"pone.0357882.ref020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/boc.201400096","article-title":"Detecting and targetting oncogenic fusion proteins in the genomic era","volume":"107","author":"MA Davare","year":"2015","journal-title":"Biol Cell"},{"issue":"12","key":"pone.0357882.ref021","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/sj.bjc.6604054","article-title":"Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer","volume":"97","author":"RK Nam","year":"2007","journal-title":"Br J Cancer"},{"issue":"11","key":"pone.0357882.ref022","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.7150\/jca.29528","article-title":"Zhu H-Q, Gao F-H. Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation. J","volume":"10","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"pone.0357882.ref023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-018-0780-6","article-title":"Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy","volume":"17","author":"S Soverini","year":"2018","journal-title":"Mol Cancer"},{"key":"pone.0357882.ref024","first-page":"5","article-title":"Premature polyadenylation of MAGI3 produces a dominantly-acting oncogene in human breast cancer","author":"TK Ni","year":"2016","journal-title":"eLife"},{"key":"pone.0357882.ref025","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3389\/fonc.2019.01482","article-title":"Cancer Metastasis: The Role of the Extracellular Matrix and the Heparan Sulfate Proteoglycan Perlecan","volume":"9","author":"Z Elgundi","year":"2020","journal-title":"Front Oncol"},{"issue":"4","key":"pone.0357882.ref026","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/1878-0261.12638","article-title":"Upregulation of BCAM and its sense lncRNA BAN are associated with gastric cancer metastasis and poor prognosis","volume":"14","author":"J Jin","year":"2020","journal-title":"Mol Oncol"},{"issue":"1","key":"pone.0357882.ref027","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1176","article-title":"Basal cell adhesion molecule promotes metastasis-associated processes in ovarian cancer","volume":"13","author":"S Sivakumar","year":"2023","journal-title":"Clin Transl Med"},{"issue":"6","key":"pone.0357882.ref028","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1523-1747.2000.00189.x","article-title":"Basal-cell adhesion molecule (B-CAM) is induced in epithelial skin tumors and inflammatory epidermis, and is expressed at cell-cell and cell-substrate contact sites","volume":"115","author":"M Sch\u00f6n","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"41","key":"pone.0357882.ref029","doi-asserted-by":"crossref","first-page":"14911","DOI":"10.1074\/jbc.RA119.007521","article-title":"Guadall A, Cochet S, Renaud O, Colin Y, Le Van Kim C, de Brevern AG, et al. Dimerization and phosphorylation of Lutheran\/basal cell adhesion molecule are critical for its function in cell migration on laminin","volume":"294","year":"2019","journal-title":"J Biol Chem"},{"issue":"10","key":"pone.0357882.ref030","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1369\/jhc.4A6597.2005","article-title":"Differential expression of laminin isoforms in ovarian epithelial carcinomas suggesting different origin and providing tools for differential diagnosis","volume":"53","author":"M M\u00e4\u00e4tt\u00e4","year":"2005","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"pone.0357882.ref031","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-018-0807-z","article-title":"Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway","volume":"17","author":"H Werner","year":"2018","journal-title":"Mol Cancer"},{"issue":"4","key":"pone.0357882.ref032","first-page":"280","article-title":"Epithelial ovarian cancer: Evolution of management in the era of precision medicine","volume":"69","author":"S Lheureux","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"pone.0357882.ref033","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bcmd.2012.10.009","article-title":"DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer","volume":"50","author":"FRM Latini","year":"2013","journal-title":"Blood Cells Mol Dis"},{"issue":"8","key":"pone.0357882.ref034","first-page":"275","article-title":"An Overview of Unfolded Protein Response Signaling and Its Role in Cancer","volume":"32","author":"BP Jain","year":"2017","journal-title":"Cancer Biother Radiopharm"},{"issue":"9","key":"pone.0357882.ref035","doi-asserted-by":"crossref","first-page":"12521","DOI":"10.1096\/fj.202000892R","article-title":"Inhibition of the PI 3-kinase pathway disrupts the unfolded protein response and reduces sensitivity to ER stress-dependent apoptosis","volume":"34","author":"JN Winnay","year":"2020","journal-title":"FASEB J"},{"key":"pone.0357882.ref036","doi-asserted-by":"crossref","first-page":"5729710","DOI":"10.1155\/2019\/5729710","article-title":"The Role of the ER-Induced UPR Pathway and the Efficacy of Its Inhibitors and Inducers in the Inhibition of Tumor Progression","volume":"2019","author":"A Walczak","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"pone.0357882.ref037","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-017-0657-0","article-title":"PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy","volume":"16","author":"IC Salaroglio","year":"2017","journal-title":"Mol Cancer"},{"issue":"1","key":"pone.0357882.ref038","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1186\/s12885-022-09648-4","article-title":"Linking unfolded protein response to ovarian cancer cell fusion","volume":"22","author":"L Yart","year":"2022","journal-title":"BMC Cancer"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:38:22Z","timestamp":1790357902000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0357882"}},"subtitle":[],"editor":[{"given":"Yoshito","family":"Nishimura","sequence":"first","affiliation":[{"name":"Mayo Clinic Rochester: Mayo Clinic Minnesota","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0357882","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}